Mirae Asset Global Investments’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
PCM
Mirae Asset Global Investments's COLL Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Collegium Pharmaceutical (COLL) stake by 12% in Q2 2026, selling an estimated $7K and leaving 1,451 shares worth $52.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1350.
Mirae Asset Global Investments first reported a position in COLL in Q2 2022 and has held it in 17 quarters since. The position peaked at $514K in Q4 2023. 101 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- Mirae Asset Global Investments held 1,451 shares of Collegium Pharmaceutical worth $52.5K as of Q2 2026.
- Mirae Asset Global Investments sold 205 Collegium Pharmaceutical shares in Q2 2026, an estimated $7K.
- Collegium Pharmaceutical made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1350 holding.
- Mirae Asset Global Investments first reported a position in Collegium Pharmaceutical in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Collegium Pharmaceutical position peaked at $514K in Q4 2023.
- 101 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.